Epoetin Injection 10000 IU, containing the active ingredient Erythropoietin Alfa, is a recombinant human erythropoietin designed to stimulate red blood cell production. It is primarily indicated for the management of anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and other conditions where endogenous erythropoietin levels are insufficient. By promoting erythropoiesis, Epoetin helps improve hemoglobin levels and reduces the need for blood transfusions, enhancing the quality of life for patients.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class
Hematopoietic growth factor

Indications:

• Chronic Kidney Disease (CKD): Treatment of anemia in patients with CKD, both on dialysis and not on dialysis.

• Chemotherapy-Induced Anemia: To manage anemia in cancer patients receiving myelosuppressive chemotherapy.

• Surgical Patients: May be used preoperatively to reduce the risk of transfusion in certain surgical procedures.

• Other Causes of Anemia: Conditions with insufficient endogenous erythropoietin.

Pharmacology
Epoetin Injection contains recombinant erythropoietin, a glycoprotein identical to endogenous human erythropoietin. It binds to erythropoietin receptors in the bone marrow, stimulating proliferation and differentiation of erythroid progenitor cells. This leads to an increased production of red blood cells, improvement in hemoglobin levels, and alleviation of anemia-related symptoms such as fatigue, weakness, and shortness of breath.

Dosage and Administration

• Adults with CKD: Typically administered subcutaneously or intravenously, with the dose individualized based on hemoglobin response. Initial dose: 50–100 IU/kg three times per week or as directed by the physician.

• Chemotherapy-Induced Anemia: Recommended dose is 150 IU/kg three times weekly or 40,000 IU once weekly subcutaneously.

• Dose adjustments should be made carefully to avoid rapid increases in hemoglobin, which may increase cardiovascular risk.

• Pediatrics: Use should be guided by specialist recommendations, considering weight-based dosing and monitoring requirements.

Contraindications

• Hypersensitivity to erythropoietin or any component of the formulation.

• Uncontrolled hypertension.

• Pure red cell aplasia (PRCA) associated with previous erythropoietin therapy.

Precautions

• Monitor hemoglobin and hematocrit regularly to adjust dosage appropriately.

• Monitor blood pressure, as Epoetin may exacerbate hypertension.

• Use with caution in patients with cardiovascular disease.

• Ensure adequate iron stores prior to and during therapy for optimal response.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Adverse Effects

• Common: Hypertension, headache, injection site reactions, joint pain.

• Less common: Thromboembolic events, pure red cell aplasia, flu-like symptoms.

Storage
Store in a refrigerator at 2°C–8°C. Do not freeze. Protect from light and use within the recommended shelf-life.

Summary
Epoetin Injection 10000 IU is a clinically proven therapy for the management of anemia in diverse patient populations. By effectively stimulating erythropoiesis, it helps restore hemoglobin levels, reduces transfusion requirements, and improves overall patient well-being. Careful monitoring of hemoglobin, blood pressure, and iron status ensures safe and effective treatment outcomes.